BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37946354)

  • 21. Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-
    Tao Z; Zhou X; Zhang Y; Pu W; Yang Y; Wei F; Zhou Q; Zhang L; Du Z; Wu J
    Mediators Inflamm; 2021; 2021():1610251. PubMed ID: 33967625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NLRP3 Inflammasome and Inflammatory Bowel Disease.
    Zhen Y; Zhang H
    Front Immunol; 2019; 10():276. PubMed ID: 30873162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.
    Wu G; Zhang D; Yang L; Wu Q; Yuan L
    Mol Immunol; 2022 Jun; 146():57-68. PubMed ID: 35447415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.
    Neudecker V; Haneklaus M; Jensen O; Khailova L; Masterson JC; Tye H; Biette K; Jedlicka P; Brodsky KS; Gerich ME; Mack M; Robertson AAB; Cooper MA; Furuta GT; Dinarello CA; O'Neill LA; Eltzschig HK; Masters SL; McNamee EN
    J Exp Med; 2017 Jun; 214(6):1737-1752. PubMed ID: 28487310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the Role of the NLRP3 Inflammasome Pathway in Acute Intestinal Inflammation: Use of THP-1 Knockout Cell Lines in an Advanced Triple Culture Model.
    Busch M; Ramachandran H; Wahle T; Rossi A; Schins RPF
    Front Immunol; 2022; 13():898039. PubMed ID: 35911682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of NLRP1 and NLRP3 inflammasome signaling pathways in the immune mechanism of inflammatory bowel disease in children].
    Wang H; Ma YC
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):854-859. PubMed ID: 32800032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis.
    Scalavino V; Piccinno E; Valentini AM; Schena N; Armentano R; Giannelli G; Serino G
    Cells; 2023 Aug; 12(17):. PubMed ID: 37681916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of immunoproteasome attenuates NLRP3 inflammasome formation in tumor necrosis factor α-stimulated intestinal epithelial cell.
    Yoon B; Yun Y; Kim KB; Kim DE
    Biochem Biophys Res Commun; 2022 Oct; 624():157-163. PubMed ID: 35944388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis.
    Zeng B; Huang Y; Chen S; Xu R; Xu L; Qiu J; Shi F; Liu S; Zha Q; Ouyang D; He X
    Cell Mol Immunol; 2022 Aug; 19(8):925-943. PubMed ID: 35799057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors.
    Singh R; Rossini V; Stockdale SR; Saiz-Gonzalo G; Hanrahan N; D' Souza T; Clooney A; Draper LA; Hill C; Nally K; Shanahan F; Andersson-Engels S; Melgar S
    Gut Microbes; 2023; 15(1):2163838. PubMed ID: 36656595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases.
    Weber S; Sitte S; Voegele AL; Sologub L; Wilfer A; Rath T; Nägel A; Zundler S; Franchi L; Opipari AW; Sonnewald S; Reid S; Hartmann A; Eichhorn P; Handtrack C; Weber K; Grützmann R; Neufert C; Schellerer VS; Naschberger E; Ekici AB; Büttner C; Neurath MF; Atreya R
    J Crohns Colitis; 2024 Mar; 18(3):446-461. PubMed ID: 37748021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?
    Ngui IQH; Perera AP; Eri R
    Molecules; 2020 May; 25(10):. PubMed ID: 32456012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of polyphenolic maqui (
    Ortiz-Cerda T; Argüelles-Arias F; Macías-García L; Vázquez-Román V; Tapia G; Xie K; García-García MD; Merinero M; García-Montes JM; Alcudia A; Witting PK; De-Miguel M
    Front Immunol; 2023; 14():1229767. PubMed ID: 38283356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potentials of mesenchymal stem cells in the treatment of inflammatory bowel disease in rats.
    Ali Mohammed S; Elbaramawy A; Hassan Abd-Allah S; Elkholy A; Ibrahim Elsayed N; Hussein S
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23532. PubMed ID: 37676835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice.
    Huang M; Wang Q; Long F; Di Y; Wang J; Zhun Zhu Y; Liu X
    FASEB J; 2020 Mar; 34(3):4107-4119. PubMed ID: 31971317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Crohn's Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy.
    Mehto S; Jena KK; Nath P; Chauhan S; Kolapalli SP; Das SK; Sahoo PK; Jain A; Taylor GA; Chauhan S
    Mol Cell; 2019 Feb; 73(3):429-445.e7. PubMed ID: 30612879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
    Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
    Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VSIG4 ameliorates intestinal inflammation through inhibiting macrophages NLRP3 inflammasome and pyroptosis.
    Liao Y; Deng C; Wang X
    Tissue Cell; 2024 Feb; 86():102285. PubMed ID: 38113649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.